ICU Medical (ICUI) Set to Release Earnings Tomorrow: Key Insights to Anticipate
Earnings Report Overview: ICU Medical is set to report its earnings this Thursday, with analysts expecting a revenue decline of 13.3% year on year to $510.5 million, and adjusted earnings of $1.43 per share.
Previous Performance: Last quarter, ICU Medical exceeded revenue expectations by 1.7%, reporting $548.9 million, although this was an 8% decrease from the previous year.
Analyst Sentiment: Analysts have maintained their estimates for ICU Medical over the past month, indicating confidence in the company's performance, as it has only missed revenue estimates once in the last two years.
Market Context: Compared to peers like Merit Medical Systems and Intuitive Surgical, which reported strong revenue growth, ICU Medical's stock has seen a 3.5% increase over the past month, with an average analyst price target of $174.83 against its current price of $125.66.
Trade with 70% Backtested Accuracy
Analyst Views on ICUI
About ICUI
About the author
ICU Medical to Present Innovative Products at 44th Annual J.P. Morgan Healthcare Conference
- Conference Participation: ICU Medical will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 1:30 PM PT, showcasing its innovations in medical products, which is expected to attract significant investor interest.
- One-on-One Meetings: The management team will also engage in one-on-one meetings on the same day, aiming to deepen connections with potential investors and foster future capital collaborations, enhancing the company's market presence.
- Live Webcast: The presentation will be webcast live on the company's website, allowing viewers to access and replay the session, which increases transparency and broadens its influence in the healthcare sector.
- Company Background: ICU Medical focuses on the development and sale of infusion systems and high-value critical care products, committed to providing quality and innovation to clinical customers worldwide, underscoring its leadership position in the medical industry.
Insiders Purchase Shares of VHT ETF Holdings
Insider Buying in Vanguard Health Care ETF: 17.6% of the weighted holdings in the Vanguard Health Care ETF (VHT) have seen insider buying in the past six months.
ICU Medical Inc Activity: ICU Medical Inc (ICUI), making up 0.05% of VHT, has had two directors and officers purchase shares recently, with the ETF holding $9,411,006 worth of ICUI.
Tandem Diabetes Care Inc Activity: Tandem Diabetes Care Inc (TNDM), the #243 largest holding in VHT, also shows insider buying from two directors and officers, with the ETF holding $3,407,114 worth of TNDM.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect those of Nasdaq, Inc.
